IVERIC bio Inc ISEE:NASDAQ

Last Price$13.01NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/18/22

Today's Change+0.23(1.80%)
Bid (Size)$12.66 (1)
Ask (Size)$15.46 (1)
Day Low / High$12.50 - 13.08
Volume1.9 M
 

View Pharmaceuticals: Generic IndustryPeer Comparison as of 08/18/2022

 

IVERIC bio Inc ( NASDAQ )

Price: $13.01
Change: +0.23 (1.80%)
Volume: 1.9 M
4:00PM ET 8/18/2022
 
 

Silk Road Medical Inc ( NASDAQ )

Price: $44.83
Change: +0.54 (1.22%)
Volume: 300.2 K
4:00PM ET 8/18/2022
 
 

Amphastar Pharmaceuticals Inc ( NASDAQ )

Price: $32.44
Change: +0.40 (1.25%)
Volume: 166.8 K
4:00PM ET 8/18/2022
 
 

BridgeBio Pharma Inc ( NASDAQ )

Price: $10.70
Change: +0.10 (0.94%)
Volume: 1.8 M
4:00PM ET 8/18/2022
 
 

Enanta Pharmaceuticals Inc ( NASDAQ )

Price: $70.21
Change: +0.46 (0.66%)
Volume: 143.7 K
4:00PM ET 8/18/2022
 

Read more news Recent News

--UBS Initiates Coverage on IVERIC bio With Buy Rating, $20 Price Target
11:30AM ET 8/02/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Sector Update: Health Care Stocks Steady Premarket Tuesday
9:27AM ET 7/26/2022 MT Newswires

Health care stocks were steady premarket Tuesday. The Health Care SPDR (XLV) was up 0.03% and the iShares NASDAQ Biotechnology Index (IBB) was recently...

IVERIC bio's Q2 Loss Widens, Company Provides Cash Guidance for 2022
7:10AM ET 7/26/2022 MT Newswires

IVERIC bio (ISEE) reported a Q2 net loss Tuesday of $0.41 per diluted share, compared with a loss of $0.32 a year earlier. Analysts polled by Capital IQ...

--Morgan Stanley Adjusts Price Target on IVERIC bio to $30 From $25, Reiterates Overweight Rating
9:19AM ET 7/07/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

View all Commentary and Analysis

IVERIC bio, Inc. (ISEE) CEO Glenn Sblendorio on Q2 2022 Results - Earnings Call Transcript
2:09PM ET 7/26/2022 Seeking Alpha

IVERIC bio: A First Take
2:16PM ET 6/23/2022 Seeking Alpha

Biopharmaceutical Stocks: The Bottoming Process Is Playing Out
2:30PM ET 6/08/2022 Seeking Alpha

IVERIC (ISEE) Investor presentation - Slideshow
10:10AM ET 5/07/2022 Seeking Alpha

Company Profile

Business DescriptionIVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. View company web site for more details
Address8 Sylvan Way
Parsippany, New Jersey 07054
Phone+1.609.474.6755
Number of Employees35
Recent SEC Filing08/04/20224
Chief Executive Officer & DirectorGlenn P. Sblendorio
PresidentPravin U. Dugel
Chief Operating Officer & Senior Vice PresidentKeith Westby
Chief Financial Officer, Treasurer & Senior VPDavid F. Carroll

Company Highlights

Price Open$12.69
Previous Close$13.01
52 Week Range$8.37 - 19.35
Market Capitalization$1.5 B
Shares Outstanding118.1 M
SectorHealth Technology
IndustryPharmaceuticals: Generic
Next Earnings Announcement11/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.22
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-46.62%

Analyst Ratings as of 08/01/2022

Buy
10
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset